NOVARTIS AG (NVSEF)
Clinical trial NCT06934967 updates: 1. completion date: 2031-12-19 → 2031-11-13 2. primary completion date: 2031-11-19 → 2031-10-14
Clinical trial NCT06934967 updates: 1. completion date: 2031-12-19 → 2031-11-13 2. primary completion date: 2031-11-19 → 2031-10-14
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical